AI assistant
Sending…
Elevance Health, Inc. — Director's Dealing 2021
Oct 29, 2021
29933_dirs_2021-10-29_841efdff-55fb-44ce-a0cd-3aca81186b1d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Anthem, Inc. (ANTM)
CIK: 0001156039
Period of Report: 2021-10-28
Reporting Person: Penczek Ronald W (SVP, Chief Accounting Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-10-28 | Common Stock | S | 1150 | $436 | Disposed | 2009 | Direct |
Footnotes
F1: Balance includes 7.79 shares acquired on March 25, 2021, 7.34 shares acquired on June 25, 2021 and 7.37 shares acquired on September 24, 2021 through a dividend reinvestment plan.
More from Elevance Health, Inc.
Interim / Quarterly Report
2026
Apr 22
Regulatory Filings
2026
Apr 22
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Feb 26
Annual Report
2026
Feb 6
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3
Regulatory Filings
2026
Jan 28
Director's Dealing
2026
Jan 14